Date: 12-Feb-2020

Zydus gets US FDA marketing approval for generic Vanos cream

Zydus Cadila has received the final approval from the US Food and Drug Administration (FDA) to market fluocinonide cream USP, (US RLD - Vanos cream) 0.1%. The drug is used to treat a variety of skin conditions (e.g., psoriasis, eczema, dermatitis, allergies, rash) and will be manufactured at the groupís topical manufacturing facility at Ahmedabad. The group now has 279 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04